GlaxoSmithKline Foundation Distinguished Professorship in Social Sciences Anticipated Hiring Range Commensurate with experience... University (NC State) invites applications at the senior associate or full professor level for the Goodnight-NC GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
on individuals and communities. ViiV Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009... is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Are you looking for a new challenge in a critical strategic...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring... their HIV assets to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
GlaxoSmithKline (GSK) is searching for a strategic, experienced, and technically adept Automation Platforms Director...
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven in our unrelenting commit...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Job Title: Payer Access Analytics Manager – ViiV Healthcare Location: Durham, NC (office 2-3 times per week) Company Overview: ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and deliv...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...